E003-1173 Screening compound: N-(2-ethoxybenzyl)-1'-methyl-9'-oxo-8',9'-dihydrospiro[cycloheptane-1,7'-furo[3,2-f]chromene]-2'-carboxamide

E003-1173 Screening compound: N-(2-ethoxybenzyl)-1'-methyl-9'-oxo-8',9'-dihydrospiro[cycloheptane-1,7'-furo[3,2-f]chromene]-2'-carboxamide
E003-1173 Screening compound: N-(2-ethoxybenzyl)-1'-methyl-9'-oxo-8',9'-dihydrospiro[cycloheptane-1,7'-furo[3,2-f]chromene]-2'-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E003-1173
N-(2-ethoxybenzyl)-1'-methyl-9'-oxo-8',9'-dihydrospiro[cycloheptane-1,7'-furo[3,2-f]chromene]-2'-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E003-1173

Molecular Formula

C28H31NO5 (C28 H31 NO5)

Compound Name

N-(2-ethoxybenzyl)-1'-methyl-9'-oxo-8',9'-dihydrospiro[cycloheptane-1,7'-furo[3,2-f]chromene]-2'-carboxamide

IUPAC name

N-[(2-ethoxyphenyl)methyl]-3'-methyl-13'-oxo-5'10'-dioxaspiro[cycloheptane-111'-tricyclo[7.4.0.0^{26}]tridecane]-1'3'6'8'-tetraene-4'-carboxamide

SMILES

CCOc1c(CNC(c2c(C)c(c(C(C3)=O)c(cc4)OC33CCCCCC3)c4o2)=O)cccc1

InChI

InChI=1S/C28H31NO5/c1-3-32-21-11-7-6-10-19(21)17-29-27(31)26-18(2)24-22(33-26)12-13-23-25(24)20(30)16-28(34-23)14-8-4-5-9-15-28/h6-7,10-13H,3-5,8-9,14-17H2,1-2H3,(H,29,31)

InChI Key

NRMXLKZISBNSQK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14836255

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

461.56

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.757

Distribution Coefficient, logD

5.757

Water Solubility, LogSw

-5.82

Polar Surface Area

59.703

Acid Dissociation Constant (pKa)

11.28

Base Dissociation Constant (pKb)

-2.01

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

42.90

E003-1173 in Drug Discovery

Included in Screening Libraries

Antiviral HBV Library (10007 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Cyclic compounds
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with E003-1173 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E003-1173?
Check Price and Availability of E003-1173, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E003-1173 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E003-1173
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E003-1173
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E003-1173 available by request